Видео с ютуба Fda Cber Director

FDA CBER Cell Therapies and Tissue-Based Products Workshop: Welcome and Opening Remarks

Keeping Pace with CGT, Dr Peter Marks, Director CBER, FDA

FDA CBER Director Peter Marks chose a more appropriate venue for his lies to ALS patients.

FDA | NIH : Regulatory Do’s and Don’ts: Tips from FDA: CBER Presentations

The FDA's Role in Gene Therapy

Resignation of a top vaccine official at the FDA

Dr. Vinay Prasad Keynote Address - NORD Scientific Symposium

КРИТИЧНОЕ ЧТЕНИЕ директора FDA: Обзор книги «Злокачественная» для инвесторов в биотехнологии и кл...

May 2021 MCCC Board of Directors Guest Speaker: Peter Marks (FDA)

Dr. Mark Makary, FDA Director | Kennedy and Trump

Shocking FDA Shakeup: Vinay Prasad Out — Huge Impact For CAPR & PGEN

FDA CBER主任 Vinay Prasad 离职，从FDA人事变动聊三个关于美国FDA的故事

FDA | NIH : Regulatory Do’s and Don’ts: Tips from FDA: CBER Q&A Panel

FDA-NIH 2024 | D1S10 - CBER’s CMC Considerations for Early Phase Studies of Cell and Gene Therapy...

The More Data We Have, the Better - CBER Director, US FDA

2024 CERSI Summit - Panel 4: FDA Center Directors Forum

FDA CBER Director Dr. Peter Marks Discusses Industry Growth, Collaboration and Communication

Ep. 71 - Pazdur Unplugged: FDA Director Richard Pazdur on the Past, Future of Cancer Treatments

FDA ramps up unannounced inspections of foreign facilities #news #pharmanews #biotechnews

Day 1, BioAsia 2021 - Keynote address by Dr. Peter Marks (Director CBER, FDA)